Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Laser Photonics Seeks Approval for Laser Treatment of Psoriasis

Photonics.com
Sep 1999
CARLSBAD, Calif., Sept. 1 -- Laser Photonics Inc. announced that its Acculase Inc. subsidiary has filed with the US Food and Drug Administration for 510 (k) clearance to commercially market its excimer laser system for the treatment of dermatological disorders, including psoriasis. The company expects to launch the product in early 2000, and has engaged Healthworld Corp. to handle advertising, contract sales, consulting, medical education, public relations and marketing research.
Laser Photonics recently completed a financing to fund capital expenditures related to marketing activities and to additional clinical trials, which are being conducted at Massachusetts General Hospital. The company said its excimer laser is designed to use fiber optics to deliver UV energy precisely to lesion sites, thereby minimizing the effects of treatment on non-affected skin.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.